Literature DB >> 33188563

Controlled drinking-non-abstinent versus abstinent treatment goals in alcohol use disorder: a systematic review, meta-analysis and meta-regression.

Jonathan Henssler1,2, Martin Müller3,4, Helena Carreira5, Tom Bschor6, Andreas Heinz2, Christopher Baethge1.   

Abstract

BACKGROUND AND AIMS: The proportion of untreated patients with alcohol use disorder (AUD) exceeds that of any other mental health disorder, and treatment alternatives are needed. A widely discussed strategy is to depart from the abstinence paradigm as part of controlled drinking approaches. This first systematic review with meta-analysis aims to assess the efficacy of non-abstinent treatment strategies compared with abstinence-based strategies.
METHODS: CENTRAL, PubMed, PsycINFO and Embase databases were searched until February 2019 for controlled (randomized and non-randomized) clinical trials (RCTs and non-RCTs) among adult AUD populations, including an intervention group aiming at controlled drinking and a control group aiming for abstinence. Following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Cochrane Collaboration guidelines, literature search, data collection and risk of bias assessment were carried out independently by two reviewers [International Prospective Register of Systematic Reviews (PROSPERO), registration no. CRD42019128716]. The primary outcome was the proportion of participants consuming alcohol at or below the recommended threshold. Secondary outcomes were social functioning, drinking reductions, abstinence rates and dropouts. Using random-effects models, RCTs and non-RCTs were analyzed separately. Sensitivity and subgroup analyses accounted for methodological rigor, inclusion of goal-specific treatment, length of follow-up and AUD severity.
RESULTS: Twenty-two studies (including five RCTs) with 4204 patients were selected. There was no statistically significant difference between both treatment paradigms in RCTs [odds ratio (OR) = 1.32, 95% confidence interval (CI) = 0.51-3.39]. Non-randomized studies of free goal choice favored abstinence-orientation (OR = 0.60, 95% CI = 0.40-0.90), unless goal-specific treatment was provided (OR = 0.79, 95% CI = 0.40-1.56), or in studies of low risk of bias (OR = 0.73, 95% CI = 0.49-1.09) or with long follow-up (OR = 1.49, 95% CI = 0.78-2.85). Effect sizes were not clearly dependent upon AUD severity. Abstinence- and controlled drinking interventions did not clearly differ in their effect on social functioning and drinking reductions.
CONCLUSIONS: Available evidence does not support abstinence as the only approach in the treatment of alcohol use disorder. Controlled drinking, particularly if supported by specific psychotherapy, appears to be a viable option where an abstinence-oriented approach is not applicable.
© 2020 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.

Entities:  

Keywords:  Abstinence; alcohol use disorder; controlled drinking; drinking goal; meta-analysis; meta-regression

Year:  2020        PMID: 33188563     DOI: 10.1111/add.15329

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  6 in total

Review 1.  Understanding low treatment seeking rates for alcohol use disorder: A narrative review of the literature and opportunities for improvement.

Authors:  Alexandra Venegas; Suzanna Donato; Lindsay R Meredith; Lara A Ray
Journal:  Am J Drug Alcohol Abuse       Date:  2021-08-31       Impact factor: 3.912

2.  Evaluation of a novel therapeutic education programme for people with alcohol use disorder in France: a mixed-methods intervention study protocol (ETHER).

Authors:  Saskia Antwerpes; Marie Costa; Marion Coste; Morgane Bureau; Gwenaelle Maradan; Christophe Cutarella; Jacques Leloutre; Olivier Riccobono-Soulier; Sophie Hedoire; Elodie Frot; Fabienne Vernier; Stéphanie Vassas-Goyard; Tangui Barré; Danielle Casanova; Patrizia Carrieri
Journal:  Harm Reduct J       Date:  2022-01-10

3.  Exploring the Potential of Implementing Managed Alcohol Programmes to Reduce Risk of COVID-19 Infection and Transmission, and Wider Harms, for People Experiencing Alcohol Dependency and Homelessness in Scotland.

Authors:  Tessa Parkes; Hannah Carver; Wendy Masterton; Hazel Booth; Lee Ball; Helen Murdoch; Danilo Falzon; Bernie M Pauly; Catriona Matheson
Journal:  Int J Environ Res Public Health       Date:  2021-11-28       Impact factor: 3.390

Review 4.  Novel Agents for the Pharmacological Treatment of Alcohol Use Disorder.

Authors:  Elizabeth M Burnette; Steven J Nieto; Erica N Grodin; Lindsay R Meredith; Brian Hurley; Karen Miotto; Artha J Gillis; Lara A Ray
Journal:  Drugs       Date:  2022-02-08       Impact factor: 9.546

Review 5.  Betaine in ameliorating alcohol-induced hepatic steatosis.

Authors:  Aisha Rehman; Kosha J Mehta
Journal:  Eur J Nutr       Date:  2021-11-24       Impact factor: 5.614

Review 6.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.